Live from the NIH registry
Studies recruiting near Rockford right now
Top 25 of 112 recruiting studies, sorted by proximity — each links to its official registry page
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 2
Interventional 125 participants sought
Northwestern Medicine: Kishwaukee — DeKalb, Illinois (27.9 mi)
· Sponsor: Northwestern University
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi)
· Sponsor: SWOG Cancer Research Network
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi)
· Sponsor: NRG Oncology
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Chronic Kidney Disease
Phase 3
Interventional 7,000 participants sought
Research Site — Rockford, Illinois (1.7 mi)
· Sponsor: AstraZeneca
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi)
· Sponsor: NRG Oncology
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Phase 2, Phase 3
Interventional 992 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
OSF HealthCare_Cardiovasc Inst — Rockford, Illinois (1.7 mi)
· Sponsor: Novo Nordisk A/S
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,524 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Evaluating the Prognostic Capability of ctDNA as a Biomarker in Pancreatic Cancer Patients Undergoing Neoadjuvant Chemotherapy
Pancreas Cancer
N/A
Observational 500 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi)
· Sponsor: Northwestern University
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
OSF Saint Anthony Medical Center — Rockford, Illinois (1.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Study of DONQ52 in Active Celiac Disease
Celiac Disease
Phase 2
Interventional 92 participants sought
Rockford Gastroenterology Associates, Ltd. — Rockford, Illinois (1.7 mi)
· Sponsor: Chugai Pharmaceutical
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Multiple conditions
Phase 2
Interventional 120 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi)
· Sponsor: National Cancer Institute (NCI)
Exactech Shoulder Post Market Clinical Follow-up Study
Osteo Arthritis Shoulders, Osteonecrosis
N/A
Observational 20,000 participants sought
OrthoIllinois — Rockford, Illinois (1.7 mi)
· Sponsor: Exactech
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
Locally Advanced Adrenal Cortical Carcinoma, Metastatic Adrenal Cortical Carcinoma
Phase 2
Interventional 48 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 3
Interventional 360 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Phase 3
Interventional 1,160 participants sought
Research Site — Rockford, Illinois (1.7 mi)
· Sponsor: AstraZeneca
A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
Atrial Fibrillation
N/A
Interventional 1,070 participants sought
Mercy Hospital — Janesville, Wisconsin (29.3 mi)
· Sponsor: Biosense Webster, Inc.
Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk
Hepatocellular Carcinoma
Phase 2
Interventional 200 participants sought
Northwestern Medicine Kishwaukee Hospital — DeKalb, Illinois (27.9 mi)
· Sponsor: Northwestern University
Effectiveness of an Automated Falls-Risk Screening and Referral Tool in the Emergency Department (ED)
Falls-Risk
N/A
Observational 30,000 participants sought
Swedish American Emergency Department — Rockford, Illinois (1.7 mi)
· Sponsor: University of Wisconsin, Madison
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma
Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma
Phase 2
Interventional 26 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Refractory Differentiated Thyroid Gland Carcinoma
Phase 3
Interventional 264 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi)
· Sponsor: SWOG Cancer Research Network